Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Taiyi Pharmaceutical is a comprehensive pharmaceutical enterprise based in Heze, Shandong Province, China. Established in 2004, the company specializes in the research, development, production, and sale of Traditional Chinese Medicine (TCM) formulations, chemical drug preparations, and pharmaceutical intermediates. Its product portfolio includes treatments for respiratory ailments, cardiovascular conditions, and general health supplements, with notable products such as Compound Paracetamol and Amantadine Hydrochloride capsules. Shandong Taiyi operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure product quality across various dosage forms including capsules, tablets, and granules. The company serves both domestic and international markets, focusing on integrating traditional herbal wisdom with modern pharmaceutical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Taiyi Pharmaceutical.